H. Bennink

发表

Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

C. Simón, A. Pellicer, J. Horcajadas, 2005, The Journal of clinical endocrinology and metabolism.

Reprint of Are all estrogens the same?

H. Bennink, 2008, Maturitas.

Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.

H. Bennink, R. Massai, A. van Beek, 2000, Human reproduction.

Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial.

U. Larsson‐cohn, N. Egberg, H. Bennink, 1998, Contraception.

Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux

A. von Eckardstein, G. Assmann, J. Elbers, 2003, Clinical endocrinology.

Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.

L. Mascarenhas, H. Bennink, J. Newton, 1998, Contraception.

A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3

I. Huhtaniemi, R. Dina, S. Ghaem-Maghami, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Reported jealousy differs as a function of menstrual cycle stage and contraceptive pill use: a within-subjects investigation

Susan C. Roberts, K. Cobey, A. Buunk, 2012 .

Fetal Estetrol (E4) Inhibits Growth Hormone (GH) Signal Transduction in Breast Cancer Cell Lines

A. Gračanin, C. Verhoeven, J. Mol, 2018, Austin Journal of Obstetrics and Gynecology.

Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer.

S. Steurer, E. Kubista, C. Singer, 2014, Carcinogenesis.

Ovarian activity suppression by two different low-dose triphasic oral contraceptives.

H. Bennink, T. Dieben, N. Exalto, 1995, Contraception.

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.

J. Foidart, C. Kluft, C. Klipping, 2017, Contraception.

Infertility: A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon® and Metrodin® in infertile female patients undergoing in-vitro fertilization

P. Devroey, M. Bonduelle, A. Steirteghem, 1995 .

Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH

P. Devroey, A. Steirteghem, M. Germond, 1992, The Lancet.

First singleton term birth after ovarian superovulation with rhFSH

P. Devroey, A. Steirteghem, B. Mannaerts, 1992, The Lancet.

Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.

B. Fauser, Z. Shoham, N. Lahlou, 1996, Fertility and sterility.

Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome

B. Fauser, P. Donderwinkel, H. Bennink, 1992, The Lancet.

Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH.

F. Ubaldi, P. Devroey, J. Smitz, 1996, Fertility and sterility.

Serum Hormone Concentrations During Treatment with Multiple Rising Doses of Recombinant Follicle-Stimulating Hormone (Puregon) in Men with Hypogonadotropic Hypogonadism

B. Fauser, Z. Shoham, N. Lahlou, 1998 .

A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.

L. Mascarenhas, J. Newton, A. van Beek, 1998, Human reproduction.

Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.

R. Wenzl, J. Spona, H. Bennink, 1993, Fertility and sterility.

Detection of DNA hypermethylation as a diagnostic tool in cervical neoplasma tool in cervical neoplasia

Henk, A. Zee, E. Schuuring, 2010 .

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist.

C. Simón, A. Pellicer, J. García-Velasco, 2011, Reproductive biomedicine online.

Clinical Applications for Estetrol Clinical Applications for Estetrol * #

M. Visser, H. Bennink, 2017 .

Estetrol prevents and suppresses mammary tumors induced by DMBA in a rat model

H. Kloosterboer, M. Visser, H. Bennink, 2012, Hormone molecular biology and clinical investigation.

Clinical applications for estetrol

M. Visser, H. Bennink, 2009, The Journal of Steroid Biochemistry and Molecular Biology.

Estetrol: A unique steroid in human pregnancy

E. Diczfalusy, C. Holinka, H. Bennink, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Are all estrogens the same

H. Bennink, 2004 .

Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin.

P. Devroey, J. Smitz, M. Camus, 1996, Human reproduction.

Introduction: Presentation of clinical data on implanon®1

H. Bennink, 1998 .

ABCE4 study: estetrol for treatment of advanced ER+ breast cancer

C. Verhoeven, Alice E. Dutman, M. Schmidt, 2017 .

Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins.

H. C. Coelingh Bennink, H. Out, B. Mannaerts, 1997, Fertility and sterility.

A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa.

H. Koppeschaar, J. Odink, A. Haspels, 1990, The Journal of clinical endocrinology and metabolism.

Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer.

S. Steurer, E. Kubista, C. Singer, 2014, Carcinogenesis.